These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12533985)

  • 1. Direct-to-consumer advertising of controlled substances.
    Roth JM
    Am J Health Syst Pharm; 2003 Jan; 60(1):91-2. PubMed ID: 12533985
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonpropositional content in direct-to-consumer genetic testing advertisements.
    Borry P; Shabani M; Howard HC
    Am J Bioeth; 2013; 13(5):14-6. PubMed ID: 23557036
    [No Abstract]   [Full Text] [Related]  

  • 3. Augmenting the argument against indirect medical advertising.
    Trafimow D
    Am J Bioeth; 2013; 13(5):21-3. PubMed ID: 23557040
    [No Abstract]   [Full Text] [Related]  

  • 4. The dilemma in regulating drug advertising: propositional versus nonpropositional content.
    Krimsky S
    Am J Bioeth; 2013; 13(5):16-7. PubMed ID: 23557037
    [No Abstract]   [Full Text] [Related]  

  • 5. Objects closer than they appear: regulating health-based advertising of food.
    Marks JH
    Am J Bioeth; 2013; 13(5):23-5. PubMed ID: 23557041
    [No Abstract]   [Full Text] [Related]  

  • 6. Don't ban the sunset in pharmaceutical advertising if it doesn't darken the sky.
    Huddle TS
    Am J Bioeth; 2013; 13(5):27-30. PubMed ID: 23557043
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to open peer commentaries on "ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising".
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):W1-5. PubMed ID: 23557060
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical companies: the perfect scapegoat for everything.
    Chang PL
    Am J Bioeth; 2013; 13(5):30-2. PubMed ID: 23557044
    [No Abstract]   [Full Text] [Related]  

  • 9. Inching toward health decision exceptionalism.
    Stark M; Fins JJ
    Am J Bioeth; 2013; 13(5):18-9. PubMed ID: 23557038
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical "nudging"--reinterpreting the ethics of evaluative conditioning.
    Ploug T; Holm S
    Am J Bioeth; 2013; 13(5):25-7. PubMed ID: 23557042
    [No Abstract]   [Full Text] [Related]  

  • 11. "Will I be pretty, will I be rich?": the missing self in antidepressant commercials.
    Tekin S
    Am J Bioeth; 2013; 13(5):19-21. PubMed ID: 23557039
    [No Abstract]   [Full Text] [Related]  

  • 12. Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising.
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):3-13. PubMed ID: 23557035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of advertising strategies in the pharmaceutical industry.
    Reuter L
    Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Caution for false advertising].
    Heinzl S
    Med Monatsschr Pharm; 2003 Feb; 26(2):37. PubMed ID: 12619521
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug firms vow to tone down consumer advertisements.
    Wadman M
    Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
    [No Abstract]   [Full Text] [Related]  

  • 16. Academic Emergency Medicine can print pharmaceutical advertising while not compromising its mission or its integrity.
    Gaddis GM; Olson JE; Wright DW
    Acad Emerg Med; 2009 Oct; 16(10):978-81. PubMed ID: 19799574
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 18. Four drug companies breach industry's code of practice.
    Hawkes N
    BMJ; 2010 Dec; 341():c7266. PubMed ID: 21163846
    [No Abstract]   [Full Text] [Related]  

  • 19. The winner takes it all.
    Walsh K
    J Med Ethics; 2005 May; 31(5):267. PubMed ID: 15863682
    [No Abstract]   [Full Text] [Related]  

  • 20. Misleading drug promotion--no sign of improvements.
    Mansfield PR; Henry D
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):797-9. PubMed ID: 15386716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.